DAVID CRAIG KIDS CHESTY COUGH BROMHEXINE (bromhexine hydrochloride) 1.6mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

david craig kids chesty cough bromhexine (bromhexine hydrochloride) 1.6mg/ml oral liquid bottle

biotech pharmaceuticals pty ltd - bromhexine hydrochloride, quantity: 1.6 mg/ml - oral liquid - excipient ingredients: saccharin sodium; sorbitol solution (70 per cent) (non-crystallising); sodium citrate dihydrate; citric acid; propylene glycol; sodium benzoate; purified water; glycerol; xanthan gum; flavour - as a mucolytic - breaks down mucus and helps clear stubborn chest congestion.

DURO-TUSS CHESTY COUGH LOZENGES berry flavour blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

duro-tuss chesty cough lozenges berry flavour blister pack

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride, quantity: 8 mg; cetylpyridinium chloride, quantity: 1.33 mg - lozenge - excipient ingredients: isomalt; citric acid; polysorbate 20; menthol; carmoisine; patent blue v; sucralose; flavour - to relieve chest congestion and soothe a sore throat associated with chesty cough.

DURO-TUSS CHESTY COUGH FORTE oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

duro-tuss chesty cough forte oral liquid bottle

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride,guaifenesin -

ROBITUSSIN MUCUS RELIEF DOUBLE ACTION oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

robitussin mucus relief double action oral liquid bottle

haleon australia pty ltd - guaifenesin, quantity: 20 mg/ml; bromhexine hydrochloride, quantity: 800 microgram/ml - oral liquid - excipient ingredients: purified water; sodium benzoate; allura red ac; citric acid; maltol; saccharin sodium; sorbitol solution (70 per cent) (non-crystallising); povidone; flavour - symptomatic relief from congested chests and coughs due to the common cold. robitussin chesty cough forte contains the expectorant guaiphenesin which increases the flow of natural secretions along the respiratory tract. it also contains bromhexine hydrochloride to liquefy and breakdown the secretions. this combinations helps break up a cough - helps loosen congestion so you can cough it up and get it off your chest.

DURO-TUSS PE CHESTY COUGH LIQUID + NASAL DECONGESTANT oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

duro-tuss pe chesty cough liquid + nasal decongestant oral liquid bottle

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride, quantity: 0.8 mg/ml; phenylephrine hydrochloride, quantity: 0.67 mg/ml - oral liquid - excipient ingredients: purified water; citric acid; hyetellose; sodium benzoate; sucralose; sorbitol solution (70 per cent) (crystallising); glycerol; flavour - provides temporary relief from cough and congestion. helps relieve nasal congestion and clears a runny nose. helps break down mucus and helps clear the chest conditions accompanied by excessive mucus secretions such as the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

BROMHEXINE HC1 3MG/ML MUCOLYTIC INJECTION FOR HORSES CATS & DOGS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bromhexine hc1 3mg/ml mucolytic injection for horses cats & dogs

virbac (australia) pty ltd - bromhexine hydrochloride - respiratory system - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - cough suppression | bronchitis | bronchodilation | cough suppressants | decongestants | expectorants | mucoid secretions | mucolytics | respiratory conditions | sinusitis

MUCODINE MUCOLYTIC AGENT TABLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mucodine mucolytic agent tablets

ceva animal health pty ltd - bromhexine hydrochloride - oral tablet - bromhexine hydrochloride guanidine active 8.0 mg/tb - respiratory system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - cough suppression | bronchitis | bronchodilation | cough suppressants | decongestants | expectorants | mucoid secretions | mucolytics | respiratory conditions | sinusitis

STRENSIQ asfotase alfa rch 28 mg/0.70 ml solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

strensiq asfotase alfa rch 28 mg/0.70 ml solution for injection vial

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

STRENSIQ asfotase alfa rch 18 mg/0.45 ml solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

strensiq asfotase alfa rch 18 mg/0.45 ml solution for injection vial

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

STRENSIQ asfotase alfa rch 12 mg/0.30 ml solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

strensiq asfotase alfa rch 12 mg/0.30 ml solution for injection vial

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.